Back to search

Pfu Therapeutics Ltd

14588101

active
Private Limited Company
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Negative net worth (-10)

Details

BANNER HOUSE, HARROW, HA1 1JR
Incorporated 12/01/2023

Compliance

Last accounts

31/01/2025

micro entity

Next accounts due

31/10/2026

On track

Confirmation statement

Last: 11/01/2026

Due 25/01/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mrs Helen Foster

director · Since 12/01/2023

DIRECTOR

BRITISH · ENGLAND · Age 49

Also on 1 other board

Mr. Keith Foster

director · Since 19/02/2024

CHIEF SCIENTIFIC OFFICER

BRITISH · ENGLAND · Age 59

Also on 1 other board

Mr Carl Ashley Morris

director · Since 19/02/2024

BIOTECHNOLOGY / BIOPHARMA SCIENTIST

AMERICAN · UNITED STATES · Age 56

Mr Mark Granville Beards

director · Since 07/04/2025

DIRECTOR

BRITISH · UNITED KINGDOM · Age 56

Also on 2 other boards

Persons with Significant Control

Mrs Helen Foster

25–50% shares
25–50% votes
Appoint directors

British · England · Age 49

Banner House, 29 Byron Road, Harrow, HA1 1JR

Notified 12/01/2023

Mr. Keith Foster

25–50% shares
25–50% votes
Appoint directors

British · England · Age 59

Banner House, 29 Byron Road, Harrow, HA1 1JR

Notified 11/01/2026

CompanyRankvs 3774+ SIC 72110 peers
24

Financial strength15th percentile among SIC peers · 4/25
Employees0th percentile among SIC peers · 0/15
LiquidityCurrent ratio 0.13× · 2/20
Longevity3 years trading (max 15) · 3/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
3774Pfu Therapeutics Ltd
24
How is this score calculated?
Financial strength4/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees0/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity3/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/01/2025

Net Worth

-£17k

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

-£10k

Working capital

Current Assets

£2k

Current Liabilities

£11k

Balance Sheet

Assets less current liabilities-£10k
Signed by Mr Keith Foster 27/01/2026Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20250.13-£8k
20240.17—

Derived from filed accounts. Not audited figures.